‘Glass – the future and £60 million funding’ is the theme for a conference on 23 July that will highlight plans for a multi-million pound research centre, expected to shape the way forward for the UK glass sector. Industry leaders from across Europe will hear how they can influence and benefit from research into clean fuels and innovation to boost manufacturing productivity. And they will set the agenda for how the £1.6 billion UK sector and its supply chain can benefit from the Glass Futures project.
A 5.5 net-metered solar project, built and operated by KDC Solar, is supplying solar power to Ardagh Group’s Bridgeton, NJ glass manufacturing facility in the USA. The leading glass packaging producer aims to minimise its environmental impact, while remaining economically sustainable and socially responsible.
Corning Inc recently hosted a meeting with investors and industry analysts in New York City to review the company’s strategic, operational and financial priorities to deliver continued growth and create additional value for shareholders. The 2020-2023 Strategy and Growth Framework will build on the success of the company’s 2016-2019 Strategy and Capital Allocation Framework and capture significant organic growth opportunities for the future. Corning expects 6%-8% compound annual sales growth, driven primarily by organic growth in the company’s market-access platforms.
Vidrala has completed the novation of a significant part of its debt towards a sustainable financing structure. Valued at €260 million, financing consists of a term loan of €80 million and a revolving credit facility of €180 million, with maturities between 2023 and 2024 that include optional extensions up to 2025. Financing cost will be equivalent to adding an initial differential of 0.75% per annum to the Euribor reference rate, which may be reduced up to 0.585% if debt continues to fall and certain environmental improvement targets are met.
UK-based Glass Technology Services, has welcomed stricter analytical requirements under the revised European Pharmacopoeia, which aims to improve the accuracy and reproducibility of hydrolytic resistance tests performed on glass primary packaging for pharmaceutical use.
In recent years, revisions to the United States and European Pharmacopoeias have seen increased harmonisation between the two monographs, including both the surface/whole article and glass grains/powder tests and an increasing emphasis placed upon the importance of assessing glass delamination risk.